NCT02262637View on ClinicalTrials.gov

Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT)

CompletedOBSERVATIONAL
Enrollment

4,814

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2006

Conditions
Hypertension
Interventions
DRUG

Micardis®

DRUG

MicardisPlus®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY